Viewing StudyNCT00003885



Ignite Creation Date: 2024-05-05 @ 10:23 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00003885
Status: UNKNOWN
Last Update Posted: 2013-11-06
First Post: 1999-11-01

Brief Title: Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia Chronic Myeloide Leukemia Myelodysplasia Lymphoma or Myeloma
Sponsor: Our Lady of Mercy Medical Center
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Keywords:
Name View
splenic marginal zone lymphoma View
recurrent cutaneous T-cell non-Hodgkin lymphoma View
stage I multiple myeloma View
stage II multiple myeloma View
stage III multiple myeloma View
recurrent adult acute myeloid leukemia View
recurrent adult acute lymphoblastic leukemia View
blastic phase chronic myelogenous leukemia View
recurrent grade 1 follicular lymphoma View
recurrent grade 2 follicular lymphoma View
recurrent grade 3 follicular lymphoma View
recurrent adult diffuse small cleaved cell lymphoma View
recurrent adult diffuse mixed cell lymphoma View
recurrent adult diffuse large cell lymphoma View
recurrent adult immunoblastic large cell lymphoma View
recurrent adult lymphoblastic lymphoma View
recurrent adult Burkitt lymphoma View
recurrent adult T-cell leukemialymphoma View
previously treated myelodysplastic syndromes View
recurrent mantle cell lymphoma View
recurrent marginal zone lymphoma View
recurrent small lymphocytic lymphoma View
extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
nodal marginal zone B-cell lymphoma View